What It Does: Northrop Grumman is a defense contractor specializing in aerospace and space systems. The company manufactures the B-21 Raider stealth bomber (entering service in 2024-2025), Sentinel intercontinental ballistic missile (ICBM), space systems (James Webb Telescope components, military satellites), and cybersecurity. The company generated $36B in FY2024 revenue, growing 5%+, with operating margins at 10%. The backlog exceeds $85B, providing multi-year visibility. Defense spending growth and geopolitical tensions (Russia, China, Middle East) are driving sustained demand. Management targets 5-6% organic revenue growth through 2026.
How the Stock Looks: NOC trades near €530 with a market cap of €130B. The stock has appreciated ~35% in the past 18 months, supported by B-21 production ramp and backlog growth. Operating margins are 10%, with limited upside given defense contracting dynamics. Free cash flow exceeds €5B annually. The valuation at 22x forward earnings is reasonable for a defense contractor with $85B+ backlog. Key catalysts include quarterly B-21 production updates, Sentinel ICBM program milestones, international sales announcements, space systems growth, and guidance updates.
What Analysts Are Saying: 22 analysts rate NOC a Buy, with consensus price target of $580. Bullish analysts from Goldman Sachs and Morgan Stanley highlight B-21 production ramp as a multi-decade program and space systems growth. Backlog provides earnings visibility. Geopolitical tensions support sustained demand. Bears at JP Morgan note defense budget uncertainty and limited margin expansion. However, analyst consensus is constructive: B-21 is a cornerstone U.S. Air Force program, space spending is accelerating, and Northrop's backlog is durable. The stock is a defense and space spending compounder with inflation-protected margins.